Daiichi Sankyo Joint Venture Set To Begin Making Vaccines Next Spring
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo and joint-venture partner Kitasato University plan to begin making vaccines by next year, drawing on experienced researchers, according to a report in Nikkei